The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 2) (OPAL-Aim 2)
OPAL-Aim 2
Innovative Strategies to Promote Biomedical HIV Prevention Uptake and Retention Among High-risk Adults at Drinking Venues in Kenya and Uganda
2 other identifiers
interventional
400
2 countries
2
Brief Summary
This study will evaluate the effect of a brief alcohol counseling intervention on PrEP and PEP adherence among adults with heavy alcohol use at high risk for HIV, while gaining insights into the facilitators, barriers, and cost-effectiveness of this approach.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 6, 2023
CompletedFirst Posted
Study publicly available on registry
September 13, 2023
CompletedStudy Start
First participant enrolled
May 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
September 10, 2025
September 1, 2025
2 years
September 6, 2023
September 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of follow up time on biomedical prevention with PrEP or PEP
The proportion of time during the 24 weeks after PrEP/PEP initiation that a person is protected from HIV with PrEP/PEP, assessed by prescription refill data. Prescription refill data will be collected from MoH medical and pharmacy records, augmented by OPAL case report forms.
Measured 24 weeks after PrEP or PEP initiation
Secondary Outcomes (3)
Proportion of follow up time on biomedical prevention with PrEP or PEP- 48 weeks
Measured over 48 weeks after PrEP or PEP initiation
Proportion of participants with unhealthy alcohol use (defined by AUDIT-C ≥3 for women, ≥4 for men, and phosphatidylethanol (PEth) ≥50 ng/mL) at week 48
Measured 48 weeks after PrEP or PEP initiation
Proportion of participants with HIV seroconversion by week 48
Measured 48 weeks after PrEP or PEP initiation
Study Arms (2)
Standard of Care (Control)
ACTIVE COMPARATORStandard of care; alcohol counseling per Ministry of Health (MoH) guidelines
Healthy Living Intervention
EXPERIMENTALHealthy Living Intervention in-person alcohol counseling with booster phone calls
Interventions
The Healthy Living Intervention (HLI) is a brief alcohol counseling intervention developed using the Information, Motivation, and Behavioral skills (IMB) model, a framework in which information, motivation, and behavioral skills are key determinants of health behavior. Participants initiating PrEP will be randomized to either HLI or standard of care alcohol counseling.
Participants who are randomized to the control arm will receive basic alcohol counseling through the Ministry of Health if it is provided as standard of care.
Eligibility Criteria
You may qualify if:
- Adult (≥18 years)
- HIV-uninfected (by rapid HIV antibody test)
- AUDIT-C score of \>=4 for men and \>=3 for women
- Attending a clinical visit for initiation of biomedical HIV prevention with oral or injectable PrEP or oral PEP (or the dapivirine vaginal ring, if available)
- Has access to a mobile phone
You may not qualify if:
- Ineligible for PrEP based on MoH guidelines
- Intention to move away from the study community in the coming year
- Gross inebriation or inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, San Franciscolead
- University of California, Berkeleycollaborator
- Makerere Universitycollaborator
- Infectious Diseases Research Collaboration, Ugandacollaborator
- Kenya Medical Research Institutecollaborator
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)collaborator
Study Sites (2)
Kenya Medical Research Institute (KEMRI)
Mbita, Kenya
Infectious Diseases Research Collaboration (IDRC)
Mbarara, Uganda
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gabriel Chamie, MD, MPH
University of California, San Francisco
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 6, 2023
First Posted
September 13, 2023
Study Start
May 17, 2024
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2027
Last Updated
September 10, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Data requests can be submitted starting 3 months after article publication and the data will be made accessible for up to 36 months. Extensions will be considered on a case-by-case basis.
- Access Criteria
- Access to trial IPD can be requested by qualified researchers engaging in independent scientific research, and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP).
Per the approved Data Sharing agreement with the NIAAA Data Archive, the investigators will share de-identified IPD from our baseline questionnaire, which includes questions about subject demographics, HIV risk, and alcohol use.